Hematology NewsWorse survival seen among black patients with MCLMarch 20, 2019Mantle Cell LymphomaLymphoma & Plasma Cell DisordersPatient & Survivor CareB Cell Lymphoma
Hematology NewsBendamustine-rituximab shines in frontline treatment of MCL, iNHLMarch 8, 2019Mantle Cell LymphomaB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsDual-targeted CAR T shows ‘clinical signal’ in NHLFebruary 24, 2019B Cell LymphomaMantle Cell LymphomaCellular TherapyTransplantationLymphoma & Plasma Cell DisordersImmuno-oncology
Hematology NewsAdding palbociclib upped responses in previously treated MCLFebruary 15, 2019Mantle Cell LymphomaB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsDaratumumab disappoints in non-Hodgkin lymphoma trialFebruary 11, 2019Mantle Cell LymphomaLymphoma & Plasma Cell DisordersFollicular LymphomaB Cell Lymphoma
Hematology NewsCombo appears to overcome aggressive L-NN-MCLFebruary 8, 2019Mantle Cell LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsFDA grants BI-1206 orphan designation for MCLFebruary 1, 2019Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsAutologous transplant linked to PFS benefit in MCLJanuary 18, 2019Mantle Cell Lymphoma
Hematology NewsZanubrutinib receives breakthrough designation for MCLJanuary 18, 2019Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsAdding umbralisib to ibrutinib produced responses in MCL, CLLJanuary 10, 2019CLLMantle Cell LymphomaAggressive LymphomasB Cell Lymphoma
Hematology NewsLenalidomide maintenance improves MCL survival after ASCTJanuary 2, 2019Mantle Cell LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsCortactin expression aids in CLL-MCL differentialNovember 28, 2018CLLMantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsRelapsed MCL: Options for treatmentNovember 15, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsFirst-line bortezomib prolongs survival in MCLOctober 25, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsIbrutinib discontinuation harms survival in CLLOctober 18, 2018CLLMantle Cell LymphomaIndolent LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
